Tg Therapeutics, Inc. (TGTX) insider trading.
In Q3 2026, insiders at Tg Therapeutics, Inc. reported 4 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $275K.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 1
- Net shares, P minus S
- -5,000
- Insiders
- 1
- Last filed
- 2026-09-14
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Charney Laurence N | Director | 4 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Charney Laurence N | S (D) | 5,000 | $54.96 | 168,640 | Form 4 |
| 2026-08-07 | Charney Laurence N | G (D) | 450 | $0 | 173,640 | Form 4 |
| 2026-08-07 | Charney Laurence N | G (D) | 500 | $0 | 174,090 | Form 4 |
| 2026-08-06 | Charney Laurence N | G (D) | 5,100 | $0 | 174,590 | Form 4 |
Transaction codes in this quarter
Get TGTX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1001316&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TGTX company page · Tg Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Tg Therapeutics, Inc. (TGTX)?
In Q3 2026, insiders at Tg Therapeutics, Inc. reported 4 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $275K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Tg Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/tgtx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.